Sign in

CIK 0001348362

  • Non-accelerated filer
  • Smaller reporting company

Lexaria Bioscience Corp.

Sign in to watch
Ticker
LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Aug 31
Incorporated
NV
Entity type
Operating
EIN
202000871
Phone
+1 250-765-6424
Business address
100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
Former names
Lexaria Corp., LEXARIA CORP.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-07-29 CHRISTOPHER RICHARD Chief Executive Officer Purchase +15,000 $0.91 $14K 65,000
2025-05-15 CHRISTOPHER RICHARD Chief Executive Officer Grant or award · Stock Options +150,000 350,000
2024-12-03 CHRISTOPHER RICHARD Chief Executive Officer Purchase +27,172 $2.47 $67K 50,000
2024-12-02 CHRISTOPHER RICHARD Chief Executive Officer Purchase +22,828 $2.24 $51K 22,828

Page 1 of 1 · 4 trades